Association between serum C-reactive protein elevation and atrial fibrillation after first anterior myocardial infarction

Clinical Cardiology

Volumn 31, Issue 10, 2008, Pages 482-487

  Gedikli, Omer ^a   Orem, Cihan ^a   Baykan, Merih ^a   Karahan, Caner ^a   Kucukosmanoglu, Mehmet ^a   Sahin, Sinan ^a   Korkmaz, Levent ^a   Yilmaz, Hulya ^a   Celik, Sukru ^a  

^a BLACK SEA TECHNICAL UNIVERSITY   (Turkey)

Author keywords

Arrhythmia; Myocardial infarction

Indexed keywords

C REACTIVE PROTEIN; ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HEPARIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NITRIC ACID DERIVATIVE;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; ECHOCARDIOGRAPHY; FEMALE; HEART ATRIUM FIBRILLATION; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PROTEIN BLOOD LEVEL; ACUTE HEART INFARCTION; AGE; CARDIOVASCULAR RISK; DIABETES MELLITUS; FIBRINOLYTIC THERAPY; HYPERTENSION; INFLAMMATION; NEPHELOMETRY; SMOKING; STATISTICAL ANALYSIS;

ATRIAL FIBRILLATION; C-REACTIVE PROTEIN; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; FOLLOW-UP STUDIES; HEART VENTRICLES; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; NEPHELOMETRY AND TURBIDIMETRY; PROGNOSIS; PROSPECTIVE STUDIES; VENTRICULAR FUNCTION, LEFT;

EID: 56349152750     PISSN: 01609289     EISSN: None     Source Type: Journal    
DOI: 10.1002/clc.20276     Document Type: Article

References (33)

1. Goldberg RJ, Seeley D, Becker RC, Brady P, Chen ZY, et al.: Impact of atrial fibrillation on the in-hospital and long-term survival of patients with acute myocardial infarction: a community-wide perspective. Am Heart J 1990;119(5):996-1001
2. Pritchett EL: Management of atrial fibrillation. N Engl JMed 1992;326(19):1264-1271
3. Behar S, Zahavi Z, Goldbourt U, Reicher-Reiss H, for The SPRINT Study Group: Long-term prognosis of patients with paroxysmal atrial fibrillation complicating acute myocardial infarction. Eur Heart J 1992;13(1):45-50
4. Tanne D, Reicher-Reiss H, Boyko V, Behar S, for The SPRINT Study Group: Stroke risk after anterior wall acute myocardial infarction. Am J Cardiol 1995;76(11):825-826
5. Hod H, Lew AS, Keltai M, Cercek B, Geft IL, et al.: Early atrial fibrillation during evolving myocardial infarction: a consequence of impaired left atrial perfusion. Circulation 1987;75(1):146-150
6. Crenshaw BS, Ward SR, Granger CB, Stebbins AL, Topol EJ, et al.: Atrial fibrillation in the setting of acute myocardial infarction: the GUSTO-I experience. Global utilization of streptokinase and TPA for occluded coronary arteries. J Am Coll Cardiol 1997;30(2):406-413
7. Eldar M, Canetti M, Rotstein Z, Boyko V, Gottlieb S, et al.: Significance of paroxysmal atrial fibrillation complicating acute myocardial infarction in the thrombolytic era. SPRINT and Thrombolytic Survey Groups. Circulation 1998;97(10):965-970
8. Pedersen OD, Bagger H, Kober L, Torp-Pedersen C: The occurrence and prognostic significance of atrial fibrillation/-flutter following acute myocardial infarction. TRACE Study group. TRAndolapril Cardiac Evalution. Eur Heart J 1999;20(10):748-754
9. Chung MK, Martin DO, Sprecher D, Wazni O, Kanderian A, et al.: C-reactive protein elevation in patients with atrial arrhythmias: inflammatory mechanisms and persistence of atrial fibrillation. Circulation 2001;104:2886-2891
10. Aviles RJ, Martin DO, Apperson-Hansen C, Houghtaling PL, Rautaharju P, et al.: Inflammation as a risk factor for atrial fibrillation. Circulation 2003;108:3006-3010
11. Libby P: Molecular basis of acute coronary syndromes. Circulation 1995;91:2844-2850
12. Rifai N, Tracy RP, Ridker PM: Clinical efficacy of an automated high-sensitivity C-reactive protein assay. Clin Chem 1999;45:2136-2141
13. Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, et al.: Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 1989;2:358-67
14. Cohen GI, Pietrolungo JF, Thomas JD, Klein AL: A practical guide to assessment of ventricular diastolic function using Doppler echocardiography. J Am Coll Cardiol 1996;27(7):1753-1760
15. Horowitz MS, Schultz CS, Stinson EB, Harrison DC, Popp RL: Sensitivity and specificity of echocardiographic diagnosis of pericardial effusion. Circulation 1974;50:239-47
16. Sanchez PL, Pabon P, Morinigo JL, Ledesma C, Martin F, et al.: Do baseline C-reactive protein levels predict the new-onset of atrial fibrillation in patients with acute coronary syndrome? Eur Heart J 2003;24:509A
17. Nagahama Y, Sugiura T, Takehana K, Hatada K, Inada M, et al.: The role of infarction-associated pericarditis on the occurrence of atrial fibrillation. Eur Heart J 1998;19(2):287-292
18. James TN: Myocardial infarction and atrial arrythmias. Circulation 1961;24:761-776
19. Flaker GC, Fletcher KA, Rothbart RM, Halperin JL, Hart RG, for Stroke Prevention in Atrial Fibrillation (SPAF) Investigators: Clinical and echocardiographic features of intermittent atrial fibrillation that predict recurrent atrial fibrillation. Am J Cardiol 1995;76(5):355-358
20. Celik S, Erdol C, Baykan M, Kaplan S, Kasap H, et al.: Relation between paroxysmal atrial fibrillation and left ventricular diastolic function in patients with acute myocardial infarction. Am J Cardiol 2001;88(2):160-162
21. Pietila KO, Harmoinen AP, Jokiniitty J, Pasternack AI: Serum C-reactive protein concentration in acute myocardial infarction and its relationship to mortality during 24 mo of follow-up in patients under thrombolytic treatment. Eur Heart J 1996;17(9):1345-1349
22. Toss H, Lindahl B, Siegbahn A, Wallentin L: Prognostic influence of increased fibrinogen and C-reactive protein levels in unstable coronary artery disease. FRISC Study Group. Fragmin during Instability in Coronary Artery Disease. Circulation 1997;96(12):4204-4210
23. Takahashi T, Anzai T, Yoshikawa T, Maekawa Y, Asakura Y, et al.: Serum C-reactive protein elevation in left ventricular remodeling after acute myocardial infarction-role of neurohormones and cytokines. Int J Cardiol 2003;88(2-3):257-265
24. Celik S, Baykan M, Erdol C, Kilinç K, Orem A, et al.: C-Reactive protein as a risk factor for left ventricular thrombus in patients with acute myocardial infarction. Clin Cardiol 2001;24(9):615-619
25. Anzai T, Yoshikawa T, Shiraki H, Asakura Y, Akaishi M, et al.: C-reactive protein as a predictor of infarct expansion and cardiac rupture after a first Q-wave acutemyocardial infarction. Circulation 1997;96(3):778-784
26. Engelmann MD, Svendsen JH: Inflammation in the genesis and perpetuation of atrial fibrillation. Eur Heart J 2005;26(20):2083-2092
27. Frustaci A, Chimenti C, Bellocci F, Morgante E, Russo MA, et al.: Histological substrate of atrial biopsies in patients with lone atrial fibrillation. Circulation 1997;96:1180-1184
28. Gabay C, Kushner I: Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 1999;340:448-454
29. Nattel S: New ideas about atrial fibrillation 50 y on. Nature 2002;415:219-226
30. Dernellis J, Panaretou M: Effects of C-reactive protein and the third and fourth components of complement (C3 and C4) on incidence of atrial fibrillation. Am J Cardiol 2006;97(2):245-248
31. Griselli M, Herbert J, Hutchinson WL, Taylor KM, Sohail M, et al.: C-reactive protein and complement are important mediators of tissue damage in acute myocardial infarction. J Exp Med 1999;190(12):1733-1740
32. Lagrand WK, Niessen HW, Wolbink GJ, Jaspars LH, Visser CA, et al.: C-reactive protein colocalizes with complement in human hearts during acute myocardial infarction. Circulation 1997; 95(1):97-103
33. Veselka J, Prochazkova S, Duchonova R, Bolomova I, Urbanova T, et al.: Relationship of C-reactive protein to presence and severity of coronary atherosclerosis in patients with stable angina pectoris or a pathological exercise test. Coron Artery Dis 2002;13(3): 151-154